Risk factors associated with relapse in Japanese patients with microscopic polyangiitis

Journal of Rheumatology

Volumn 39, Issue 3, 2012, Pages 545-551

  Wada, Takashi ^a   Hara, Akinori ^a   Arimura, Yoshihiro ^b   Sada, Ken Ei ^c   Makino, Hirofumi ^c   Amano, Koichi ^d   Ito, Satoshi ^e   Usui, Joichi ^e   Kumagai, Shunichi ^f   Kobayashi, Shigeto ^g   Takasaki, Yoshinari ^h   Tanemoto, Kazuo ⁱ   Dobashi, Hiroaki ^j   Harigai, Masayoshi ^k   Fujii, Takao ^l   Fujimoto, Shouichi ^m   Homma, Sakae ⁿ   Muso, Eri ^o   Murakawa, Yohko ^p   Yamada, Hidehiro ^q   Yumura, Wako ^r   Yoshida, Masaharu ^s   more..

^a KANAZAWA UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Juntendo University Hospital   (Japan)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ KAWASAKI MEDICAL SCHOOL   (Japan)

^j KAGAWA UNIVERSITY   (Japan)

^k TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^l KYOTO UNIVERSITY HOSPITAL   (Japan)

^m UNIVERSITY OF MIYAZAKI   (Japan)

ⁿ TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^o Kitano Hospital   (Japan)

^p SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^q ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r JICHI MEDICAL UNIVERSITY   (Japan)

^s TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

more..

Author keywords

Antineutrophil cytoplasmic antibody; Microscopic polyangiitis; Relapse; Risk factors

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; TACROLIMUS;

AGED; ALGORITHM; ARTICLE; COHORT ANALYSIS; ERYTHROCYTE COUNT; FEMALE; HUMAN; JAPANESE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE COUNT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; JAPAN; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULITIS;

EID: 84857856555     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110705     Document Type: Article

References (23)

1. Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: Etiology, prognosis and treatment diversity. Clin Exp Nephrol 2009;13:633-50.
2. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005;143:621-31.
3. Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts. Arthritis Rheum 2008;58:2908-18.
4. Hashimoto H, editor. Clinical manual for vasculitis. Tokyo: Research Group of Intractable Vasculitis, Ministry of Health, Labor, and Welfare of Japan; 2002.
5. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222-7. (Pubitemid 46226058)
6. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 2007;66:283-92. (Pubitemid 46579626)
7. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371-80. (Pubitemid 27114101)
8. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009;68:310-7.
9. Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D'Cruz D, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology 2007;46:1-11.
10. Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007;66:605-17. (Pubitemid 46707128)
11. The R Project for Statistical Computing. 2008. [Internet. Accessed November 4, 2011.] Available from: www.r-project.org
12. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44. (Pubitemid 36765101)
13. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, et al. Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-30. (Pubitemid 29136088)
14. Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine 2000;79:222-33.
15. Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003;49:93-100. (Pubitemid 36286135)
16. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-75. (Pubitemid 32234626)
17. Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: How and when do they start? Arthritis Rheum 2003;49:709-15. (Pubitemid 37296478)
18. Walsh M, Merkel PA, Mahr A, Jayne D. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis. Arthritis Care Res 2010;62:1166-73.
19. Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL. Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 2003;63:1079-85. (Pubitemid 36315587)
20. Tervaert JW, Stegeman CA, Kallenberg CG. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:241-5. (Pubitemid 26332265)
21. Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: A retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine 2005;84:323-30. (Pubitemid 41368485)
22. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468-74. (Pubitemid 36350012)
23. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: The Framingham study. Am Heart J 1984;108:1347-52. (Pubitemid 15210767)